The drug "Concor" is a tool designed to treat cardiovascular diseases. The pharmacological affiliation of this medication is a group of beta 1-adrenoblockers. The drug produces an effect on the body that contributes to the provision of antihypertensive, antiarrhythmic and antianginal effect.
Medication Concor is a medicine that blocks the effect of adrenaline on the heart muscle. The drug is a long-acting beta-1-blocker. With the appointment of the drug "Concor", experts' reviews confirm this, the function of conduction and excitability of the myocardium is inhibited due to the blockade of neural receptors sensitive to adrenaline located in the heart.
The hypotensive effect of the drug is associated with an effect on the central nervous system, a decrease in the volume of the minute blood flow, a decrease in the activity of the renin-angiotensin system, and deactivation of sympathetic stimulation of peripheral vascular vessels.
The antiarrhythmic effect of the medication is manifested as a result of a slowing of the rate of rhythm (ectopic and sinus), as well as atrioventricular conduction in the antegrade and additional directions.
Reducing the need for oxygenation of the myocardium with a drug as a result of a decrease in the frequency of contractions of the cardiac muscle causes an antianginal effect of the drug on the body.
The drug "Concor", the experts' comments on the use of which speak about its selective action, helps suppress the influence of adrenaline only on the heart muscle. As a result of this process, the contraction of the myocardium becomes less frequent and the arteries of the coronary bed expand. The volume of the blood expelled by the heart muscle decreases, which helps to reduce the pressure.
The use of high doses of the drug contributes to the effect on organs that contain beta 2-adrenergic receptors - such as skeletal muscles, bronchi, uterus, pancreas, peripheral artery arteries, smooth muscles.
It is recommended the use of medication for ischemia of the heart muscle. The drug "Concor", the experts' reviews of which speak of his support in a state of relaxation of the coronary vessels, shows its medicinal properties during the day after admission. As a result of the action of the drug, angina attacks completely disappear or their frequency and intensity decrease.
It is recommended to use the drug in the treatment of hypertension. The drug improves the patient's condition and normalizes blood pressure. It is recommended that the drug "Concor", whose reviews testify to its wide application in cardiology, with heart failure that is chronic. However, with this disease it is necessary to take into account the state of the myocardium. If he copes with his work to a large extent, then the purpose of the drug is fully justified. When the decompensation stage occurs, which manifests itself in the appearance of various symptoms (dyspnea, edema, etc.), the drug may cause a worsening of the severity of the pathological process.
Active active substance of the drug is bisoprodol fumarate. Its content in the medicinal form of the drug, which is coated tablets, is five or ten milligrams. Manufacturers of medical products are issued a therapeutic tool "Concor Cor," which is spoken about by its milder impact on the body. The content of bisoprodol fumarate in the drug form is two and a half milligrams. In this regard, the drug "Concor Cor" is not prescribed for the course of treatment of hypertension and angina, as it does not have the ability to normalize blood pressure.